Publication | Closed Access

A novel FAPα-based Z-Gly-Pro epirubicin prodrug for improving tumor-targeting chemotherapy

Medicinal ChemistryDrug TargetingMedicineTumor-targeting ChemotherapyPharmacotherapyAnti-cancer AgentTumor TargetingCancer TreatmentPharmacologyRadiation OncologyCancer ResearchTumor BiologyDrug Discovery